UNSPSC 85877443: Fluoroscopy of right kidney using low osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of right kidney using low osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code BT111ZZ

UNSPSC 85877443 Fluoroscopy of right kidney using low osmolar contrast is a Commodity code that in practice encompasses diagnostic medical imaging systems, equipment, and ancillary services that state and local health care providers and public safety agencies are actively procuring. The recent opportunities posted under this code show a significant mismatch between the code's nominal scope — a single specialized radiological procedure — and what public agencies are actually buying: enterprise-grade Picture Archiving and Communication Systems (PACS) platforms, ultrasound equipment, and clinical laboratory services including phlebotomy. San Mateo County Medical Center, Collier County, Florida, and the Albuquerque Police Department all represent issuing bodies sourcing medical diagnostic and imaging equipment or services, but the code's narrow procedural definition does not align with the breadth of infrastructure and operational services these jurisdictions are seeking.

Geographic activity is scattered across California, Florida, and New Mexico. San Mateo County Medical Center posted an RFP for enterprise PACS implementation supporting radiology, cardiology, and mammography with proposals due August 7, 2026, and is offering a 5–10% local preference under San Mateo County Ordinance Code Chapter 2.89; Collier County issued a Notice of Intent to single-source ultrasound equipment from EchoNous, Inc. with a posting date of April 1, 2026; and the Albuquerque Police Department issued an RFB for on-call blood draw services with a closing date of February 25, 2026. The code shows limited recent activity overall, and the opportunities that do appear under it represent operational medical services and capital equipment acquisitions that fall outside the specific fluoroscopy procedure the code nominally describes. Firms evaluating this code should expect infrequent, highly varied solicitations and should verify that individual opportunities are truly seeking fluoroscopy-related services rather than broader diagnostic infrastructure before investing business development resources.